Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1519-2017Class II

Teleflex Green Non-Latex Robertazzi Nasopharyngeal Airway, Catalog No. 123130 and 123132

Teleflex Medical / initiated 2017-01-13 / Terminated / root cause: labeling and UDI

Teleflex Medical began a recall of Teleflex Green Non-Latex Robertazzi Nasopharyngeal Airway, Catalog No. 123130 and 123132 Product Usage: To provide a patent airway for a patient with a... on . FDA classified it as Class II and gives the reason as "Labeling error". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1519-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Teleflex Medical
Product
Teleflex Green Non-Latex Robertazzi Nasopharyngeal Airway, Catalog No. 123130 and 123132 Product Usage: To provide a patent airway for a patient with a blockage or potential blockage of the nasal cavity or nasopharynx.
Product code
BTQ Airway, Nasopharyngeal
Reason for recall
Labeling error
Root cause tag
labeling and UDI
FDA root cause
Unknown/Undetermined by firm
Action
Consignees were notified of the recall by letter on 1/13/2017. The letter requested that they immediately discontinue use and quarantine the recalled product. Distributors were requested to conduct a sub-recall. The letter included a reply form which was to be returned to Teleflex.
Quantity in commerce
7,600 eaches
Distribution
Worldwide Distribution - US Nationwide in the state of AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MD, MA, MI, MN, MS, MO, NV, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, and the countries of Canada and Mexico.
Product codes and lots
Lot/Batch Numbers 16A14 and 16A14

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1519-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1519-2017Class IITerminatedVoluntary: Firm initiated